Curiato Builds Biomedical Technology Solution for Wound Care Management

Co-Founder of Curiato, Moazam Khan, is in the business of helping healthcare institutions provide better care to their patients. Curiato’s mission is to help healthcare institutions who are dissatisfied with outdated, complex and manual ways of wound care management with innovative biomedical technology.

Hack-a-thon Inspires the Creation of Curiato

Believe it or not, the focus on wound care management came after an experience attending a “Hack4Health” hack-a-thon in 2015. Moazam and co-founders Zied Etleb and Matthew Sefati were curious to understand the current challenges in the healthcare system and how they might use their skills in biomedical sciences and technology to help.

One healthcare issue in particular opened Moazam’s eyes when he had the opportunity to hear from many healthcare professionals and patients at the hack-a-thon. Something that came up over and over again was the issue of wound care management and bedsores. Bedsores — also called pressure ulcers and decubitus ulcers — are injuries to skin and underlying tissue resulting from prolonged pressure on the skin. Bedsores most often develop on skin that covers bony areas of the body, such as the heels, ankles, hips and tailbone.

Patients with limited mobility end up laying for extended periods of time creating pressure on certain areas of the skin, resulting in bedsores which can be pretty detrimental to one’s overall state of health and costly to the medical institution as a whole.

Curiato made sure to spend their time properly understanding the issue from all angles so they could build a system-based solution which would alleviate healthcare professionals and assist them (rather than creating more work) which would tackle the very real problem that patient’s are experiencing. “Creating a band-aid solution is just not an option for us, this is something that affects a lot of lives and in some cases, when palliative care comes into play, it can make an immense difference in quality of life and comfort. This is something we take seriously and are determined to make a real difference in for health care institutions, care providers and patients.”

The Solution: The Ceylon System

The solution that Moazam, Zied and Matthew began building is called the Ceylon System. The Ceylon System is a combination of a smart biological mat and patient management interface that provides monitoring of biological factors of high acuity patients, aimed towards decreasing nurse fatigue, and simplifying communication between care staff and providers. Bridging the intersection of IoT and artificial intelligence, this intuitive system has a built in monitor that can sense when a patient is at risk of developing a bedsore and when a patient needs to be moved to avoid that from happening. The Curiato founders strongly believe that the interaction and interpretation with the data is more important than the data itself.

1 bedsore can mean more hospital costs, transfer of care, re-admittance to a long-term facility, etc which in the end costs medical institutions money, time and effort. To prevent 1 bedsore could make a big difference not only to the institution, but to the staff and the patient’s.

Once they had a better understanding of why bedsores form and how this problem occurs, through 8 months of research and 2 months of interviewing healthcare professionals, they were ready to begin producing the system.

Since joining the AC Jumpstart Program, the team at Curiato was able to make some big leaps forward. Moazam said the money and mentorship was instrumental in helping with product development costs, connecting with the right talent, networking, testing, forming a corporate structure, securing business relationships and partnerships and now preparing for two pilot programs in Waterloo and Toronto for 2018.

What’s Next?

Right now, the team is focused on growing the team and preparing for the pilot programs for 2018. They are looking for engineers, data scientists and a clinical advisor board. To learn more or talk directly to the team visit: http://curiato.com/

 

Penta Medical Changes the Healthcare Game with Wearable Technology, Helios

Alexa Roeper is the driving force behind an innovative medical science product called Penta Medical. She has a background in biomedical science, is an avid horseback rider, and an athlete. It was a personal injury after horseback riding that inspired her to look into alternative healing methods, which ultimately led to the creation of her company.

Alexa experienced an injury years ago that was predicted to take her months to recover. Being an active and motivated (or self proclaimed, impatient) athlete ready to jump back in, she began thinking of all the other people that must experience this frustration with limited options available to expedite the healing process. That is when Alexa began exploring ideas to help not only herself heal faster, but others as well. The result was a serious fascination with the science of infrared therapies and how to innovate and build on that existing service to offer a more convenient, fast and mobile way to help those with muscular and or skeletal injuries heal faster.

 

 

Wearable Medical Technology! How Does It Work?

As a business owner, athlete and young professional, Alexa understands how busy life can be, to the point where it can interfere with getting proper healthcare, especially after experiencing sport related injuries. Many athletes, both amateur and professional, can experience lingering effects from previous injuries, so Penta developed a wearable product called Helios.

Helios delivers infrared therapy, a widely adopted method used at physiotherapy clinics, to the areas of injury or pain. The current prototype, operates much like an adjustable armband, that can be worn directly on the injured area, which then helps accelerate patients’ recovery. Helios is a way to effortlessly treat injuries and pain management from the comfort of your home (or anywhere you find yourself in a day). It is light, mobile and therefore patients can go about their day, and while doing so, “speed healing”, on their terms and within their schedule. Alexa shares, “Our goal with this technology is to make healthcare easily accessible and mobile, like many of our lives in this digital, fast paced world.”

How Did They Do It?

Alexa and co-founder Daniel Choi have been working hard and over the last year have accomplished a great deal. Penta, which got it’s start in the Velocity Science Program has also been a part of the Fierce Founders program, has pitched and secured 250K in investments, and is a part of the Accelerator Centre’s AC Jumpstart program.

Penta’s AC Jumpstart Experience

We asked Alexa what she and her team got out of the AC Jumpstart experience and this is what she had to share,

“AC Jumpstart has been instrumental in our company’s growth. Through funding and resources we were able to build the prototype of our wearable tech, Helios with a digital app which allows for health and injury-healing tracking. I love the transparency with which the AC communicates with each of their AC Jumpstart clients. We are all a big family and know exactly what to expect of the experience.

Additionally, the mentorship has been so helpful. Each mentor truly cares about you and your company’s growth. I love how each of them have gone above and beyond to help us on our journey. We were able to secure funding, set up speaking engagements and get some valuable press including a story in the Globe and Mail, all thanks to their help and guidance. I love this program, can’t say enough about that, haha!”

Penta is currently teaming up with various sports teams and a couple clinics in the Kitchener-Waterloo region to test out the new wearable product/app Helios, track the progress and experiences multiple patients have with various injuries to continue improving and building wearable products that help to heal those on the go!

Penta’s mission is to change the future of healthcare, one wearable at a time!

AC JumpStart is made possible by and investment from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) and is delivered in partnership with Conestoga College, Laurier, and the University of Waterloo.

AceAge Lands Strategic Agreement with Centric Health

Originally published on centrichealth.ca

Centric Health Announces Strategic Agreement for Innovative Medication Delivery Appliance

Aug 9, 2017

— Unique healthcare device transforms prescription medicine compliance and adherence —

TORONTO, Aug. 9, 2017 /CNW/ – Centric Health Corporation (“Centric Health” or “the Company”) (TSX: CHH), Canada’s leading diversified healthcare company, today announced that it has signed a strategic distribution and supply agreement and a strategic investment with AceAge Inc. (“AceAge”) for its “Karie” home-based automated drug delivery appliance.

Feel safe that your loved ones are taking their medicines correctly: Karie is an innovative technology appliance that simplifies and monitors the administration of multiple medications, improving compliance and reducing adverse drug complications. Its easy-to-load cartridge uses a multi-dose medicine package, like that produced by Centric Health. (CNW Group/Centric Health Corporation).

Designed for individuals taking multiple medications, particularly seniors living independently or without full-time care, Karie is an innovative device that makes it simple to follow complex medication regimes by automatically delivering prescription drugs, in the correct dosage and at the right time. The medication comes pre-organized in an easy-to-load cartridge and the patient’s medication schedule is also stored. Karie goes off like an alarm clock when it’s time for each dose and provides a visual and audio alert. It can also be set to automatically notify a family member or caregiver if a dose is ever missed.

“With about 70 percent of all seniors taking five or more drugs per day and improper medication compliance being a leading cause of visits to the ER and hospital admissions for seniors, Karie is an ideal solution that is completely aligned with Centric’s focus on delivering the highest levels of patient care,” said David Cutler, President and Chief Executive Officer of Centric Health. “The device is completely compatible with our automated dispensing and packaging systems and we see many opportunities for placement with seniors in our contracted retirement homes where it will improve safety and provide peace-of-mind to caregivers.” It is estimated that up to 10% of all hospital admissions are due to adverse drug reactions.

A personal solution that will benefit many
A family member of AceAge’s CEO, Spencer Waugh, was the inspiration behind Karie’s creation. After watching them be admitted to a hospital eight times in one year because they could not keep their drugs organized, Spencer sought a better solution to ensure that medication could be more easily managed. Karie incorporates both ease of use and advanced monitoring and connectivity. It uses a simple, single-load action cartridge and delivers medication with the push of just one button. It also incorporates facial recognition which ensures the safety of the user and protects others, network connectivity using TELUS’ cellular IoT network and is Bluetooth-enabled to connect to other health monitoring devices. Click here to see a video demonstration of Karie. Expected pricing will be an initial cost of $150 and $60 per month thereafter.

The appliance is in its second phase of testing in a clinical trial at the University of Toronto; AceAge is beginning production with delivery expected in spring 2018. In addition to serving the needs of seniors, Karie is an effective solution for anyone managing multiple medications and for clinical researchers conducting drug trials.

“It’s incredibly exciting to see something that we’ve been working on for so long become a reality,” said Spencer Waugh, CEO of AceAge “As we are scaling up to build and deploy thousands of devices, we see Karie as the central fixture of the connected health home.”

Terms of the agreement
Centric Health has signed a strategic distribution and supply agreement with AceAge for the device in Canada and has made a strategic investment. The cash investment of $2 million will be made in two tranches, in exchange for a 20 percent ownership interest and subscription of 20 percent of AceAge’s common shares on a fully diluted basis. Centric will have the option to acquire an additional 10 percent at a predetermined premium to its initial investment. David Cutler will have a seat on AceAge’s Board of Directors for the period that Centric remains a shareholder.

“As one of the largest providers of pharmacy services to seniors in Canada, Centric was a natural partner to work with as we launch Karie in markets across the country and internationally,” added Mr. Waugh. “With Centric we will be able to have a positive impact on many seniors, helping them to live healthy, independent lives.”

About Centric Health
Centric Health’s vision is to be Canada’s most respected and recognized provider in the independent healthcare sectors in which it operates, world renowned for delivering the highest levels of quality care and outcomes, innovative solutions and value to patients, clients and stakeholders. To this end, Centric Health primarily focuses on two core healthcare businesses:

The Specialty Pharmacy division is a “Patient First” model composed of a growing national network of fulfilment centres that deliver high-volume solutions for the cost effective supply of chronic medication and other specialty clinical care services, serving more than 29,000 residents in over 425 seniors communities (long term care facilities, retirement homes and assisted living facilities) nationally. The Specialty Pharmacy division also provides pharmaceutical dispensing services for employees insured by corporate health plans.

The Surgical & Medical Centres division is Canada’s largest independent surgical provider operating five facilities across four provinces. It serves a diversified customer base with private paid non-insured surgeries and diagnostics, government outsourcing of insured surgeries and diagnostics and other procedures funded by third-party payors (including Workers Compensation) and is the proud owner of Canada’s first Centre of Excellence in Metabolic and Bariatric Surgery.
With national networks of facilities in each of its businesses, deep knowledge and experience of healthcare delivery and extensive, trusted relationships with payers, physicians, and government agencies, the Company is uniquely positioned to address current and future healthcare needs in growing markets as the Canadian healthcare industry goes through a major transformation over the medium to long term. www.centrichealth.ca

About AceAge – www.aceage.com
AceAge Inc. is a healthcare technology company, creating beautiful and intuitive products to ease the aging process. Launching in spring 2018, Karie will be AceAge’s first commercially available product, making medication management as simple as possible. Outfitted with a front facing camera, and Bluetooth connectivity, AceAge plans for Karie to become the central fixture of the connected health home. For more information and to register for updates on Karie please visit www.kariehealth.com.

SOURCE Centric Health Corporation

For further information: David Cutler, Chief Executive Officer, Centric Health Corporation, 416-619-9401, david.cutler@centrichealth.ca; Craig MacPhail, Investor Relations, NATIONAL Equicom, 416-586-1938, cmacphail@national.ca; Spencer Waugh, Chief Executive Officer, AceAge Inc., 289-400-0811, spencer@aceage.com

Big Science Out Of A Small Lab

Originally published in the Record
KITCHENER — In the lab at Rapid Novor, a molecular scientist lays bare the microscopic-building blocks of antibodies that are increasingly used in the fight against cancer, diagnostics and new medicines.

Rapid Novor, a startup that went through the Accelerator Centre in the David Johnston Research and Technology Park, is now based at 44 Gaukel St. in downtown Kitchener. Specializing in what’s called protein sequencing, the six-member team is among a small, but growing, number of biotech startups in the region.

The human body produces antibodies to fight diseases and infections. Antibodies are made of protein. And protein is made of amino-acids — the building blocks of human life.

There about 20 common types of amino acids. Rapid Novor has combined its software with the latest in laboratory equipment and, after investing a million dollars to open the lab, it can quickly determine which amino acids make up an antibody. Just as importantly, it discovers the order, or sequence, of those amino acids, which are long, chain-shaped molecules.

That information is used to make drugs, diagnose diseases and treat cancer, said Zac McDonald, a molecular scientist and biochemist at Rapid Novor.

“That’s why the interest in it is so high because there is a lot of potential for using antibodies in cancer treatment,” said McDonald.

The antibodies can direct drugs to the right targets or block certain pathways associated with cancer.

“It is a huge, multibillion market,” said McDonald, who emigrated from South Africa in April to join the startup in downtown Kitchener.

The lab where McDonald works is the first of its kind in this region, and among the few anywhere that has the equipment for what is called next-generation-protein sequencing.

Traditionally, that would take up to two months to do Rapid Novor can do in one week. It is because of the latest equipment in mass spectrometry lab coupled with the algorithm developed by one of the startup’s co-founders — Dr. Bah Ma, the president and chief scientist at Rapid Novor. Ma is also a professor at the University of Waterloo.
Gene sequencing is not new. Using a sample of saliva, there are companies that sequence the genes in your DNA to see what diseases or conditions you are likely to develop during your lifetime, or where your ancestors are from. That’s called genomics.

Protein molecules are made up of long chains of amino acids. Identifying the different parts of that chain, and the correct order of those parts, is called proteomics. Rapid Novor has the first proteomics-grade lab in this region.

It April 2015 Ma, a professor at the Cheriton School of Computer Science at the University of Waterloo, was ready to commercialize his algorithms that automated a key part of this scientific field. The sophisticated machines analyze the protein samples, identifying the amino acids and producing huge amounts of information.

In the past it would take a scientist up to two months to sort all of that information. Ma’s algorithm does that automatically and quickly. Rapid Novor can have results for clients, which include big and small pharmaceutical companies, in three weeks. For a special fee it can be done in as little as one week.

In the past year, it has completed the protein sequence for 120 antibodies.

Mingjie Xie, a co-founder and chief executive officer, said there are tens of thousands, even hundreds of thousands of pieces that make up a protein sequence. The antibody samples that arrive in the lab are in a solution and, at 200 micrograms, are invisible.

After adding enzymes, shaking, spinning and heating a sample, the antibody is broken into its different parts, and ready for analysis in a mass spectrometer machine. That information, coupled with the startup’s algorithms, puts this small lab at the cutting edge.

“This technology is fairly new,” said Xie. “To be able to use it in commercial settings, this is very new service.”

Intellijoint Surgical and Corin Group enter strategic partnership for intellijoint HIP

Waterloo, Ontario, March 17, 2016 – Intellijoint Surgical Inc., a privately held Canadian medical technology company committed to developing and commercializing miniaturized surgical smart tools announced today the signing of a distribution agreement with Corin Group. The deal gives Corin distribution rights for Intellijoint’s flagship product, intellijoint HIP, in Australia and paves the way for broader distribution and co-development between the two companies.

intellijoint HIP provides surgeons with vital intraoperative measurements in real time, enabling proper establishment of cup position, equalization of leg length and restoration of hip offset. These critical measurements enable surgeons and hospitals to improve surgical outcomes by reducing uncertainty and risk, while improving patient outcomes and economics.

Russ Mably, Corin’s Chief Operating Officer commented, “We are delighted to partner with such a progressive company as Intellijoint Surgical, and are excited about our future collaboration. This partnership will further strengthen our market leading position in functional implant positioning with our existing OPS Technology (Optimized Positioning System), and underlines our commitment to continue to invest in Personalized Procedural Innovation”.

“We are pleased to partner with Corin to offer intellijoint HIP to surgeons in Australia.  The broader capability of Corin’s organization and their commitment to innovation will expand access to the latest technology available for 3D surgical measurement to the growing Australian hip replacement market where surgeons currently perform about 45,000 procedures annually.  We look forward to the beginning of a meaningful relationship between our two companies and are excited about future opportunities,” says Armen Bakirtzian, Chief Executive Officer and Co-founder of Intellijoint Surgical.

About Intellijoint Surgical Inc.

Intellijoint Surgical is a Waterloo-based innovative medical technology company. Founded in 2010, they develop and commercialize miniaturized surgical smart tools that enhance surgeon accuracy, increase hospital economic efficiencies, and improve patient outcomes.  The company’s R&D team is led by the former co-founder of Medtronic’s computer assisted surgery division, and driven by a team of renowned orthopaedic surgeons:  Drs. Allan Gross and David Backstein in Toronto, Dr. Wayne Paprosky in Chicago, Dr. Javad Parvizi in Philadelphia and Drs. Michael Cross and Ran Schwarzkopf in New York.

About Corin Group

As a leader in orthopaedic innovation, Corin has pioneered a number of landmark developments since it was founded in 1985. Corin is very proud to have been able to improve the quality of life of hundreds of thousands of patients around the world through the introduction of these groundbreaking products, and believes that this heritage distinguishes Corin within the global orthopaedic market. Corin’s talented and dedicated teams share a common commitment – to deliver quality orthopaedic products, procedural innovation technologies and services to patients, surgeons and healthcare providers, which exceed their expectations and positively impact their lives, through Responsible Innovation.

AC Grad Client Outlook Forms strategic partnership with lifeIMAGE

eunity-emr-exampleNEWTON, Mass.–(Business Wire)–lifeIMAGE, a leading medical image exchange network connecting health care networks, providers and patients, announced today that it has formed a strategic relationship with Client Outlook that will make its renowned visualization platform a core component of the lifeIMAGE offering. Through this partnership, Client Outlook’s FDA Class II diagnostic and clinical imaging viewing solution eUnity, broadly recognized as healthcare’s fastest and most scalable image viewing platform, will become the default viewer across all apps and services on the lifeIMAGE enterprise image exchange platform.

lifeIMAGE sought out a partner to ensure long-term access to cutting-edge viewer technology for its rapidly expanding customer base. Client Outlook, an independent organization exclusively focused on the development of its visualization platform, is consistently at the forefront of imaging innovation and has demonstrated the ability to scale its FDA-approved viewer to thousands of users at large healthcare enterprises. Its standards-based tools are interoperable with every picture archiving and communication system (PACS), vendor-neutral archive (VNA) and electronic health record (EHR), matching lifeIMAGE’s core commitment to connect image data from all sources, to any user or system.

“We wanted our customers to have assured availability to the highest quality viewing technology of today backed by an organization sharing the same commitment we’ve shown to future innovation and interoperability. We get the best of both worlds for our customers by making Client Outlook a core part of the lifeIMAGE platform,” said Matthew A. Michela, CEO and President of lifeIMAGE. “Our combined solutions create a game-changing enterprise image management opportunity for the imaging market.”

Under the terms of the partnership, Client Outlook and lifeIMAGE will collaborate to ensure the interoperability of image data across their services. Client Outlook will introduce a unique workflow that enables the fast transmission of studies and clinical information displayed on its viewer through the lifeIMAGE network, and lifeIMAGE is now the only major image exchange provider offering enterprise access to the eUnity universal viewer. Institutions seeking an integrated and single viewer experience for exams produced both inside and outside their network can deploy eUnity enterprise-wide because of this relationship.

“In partnership with lifeIMAGE we see the clear opportunity to significantly improve image data interoperability while improving physician workflow and clinical outcomes,” said Steve Rankin, President and CEO of Client Outlook. “We look forward to combining our technology with the lifeIMAGE platform to create a powerful enterprise imaging solution for our joint customers.”

 

Aultman Hospital Goes Live with Client Outlook’s eUnity

AC Grad’s Universal Image Viewer Provides All Users With Anywhere, Anytime Access to Diagnostic Quality Images Regardless of Underlying System

WATERLOO, ON (Marketwired – January 13, 2016) – Client Outlook Inc., a leading provider of FDA Class II diagnostic and clinical image viewing solutions, announced today that Aultman Hospital, Stark County Ohio’s largest hospital and largest employer, has gone live with Client Outlook’s eUnity™. The universal image viewer is now used hospital-wide by more than 2,000 physicians, referring physicians, residents, nurses and registered practical nurses for anywhere, anytime viewing of diagnostic quality images.

Aultman chose eUnity for its truly universal nature. Unlike the proprietary solutions offered by vendor neutral archive (VNA) vendors, eUnity is truly 100 percent agnostic. The viewer can be implemented on top of any PACS or any VNA, eliminating painful upgrades for users while completely future-proofing the imaging workflow. This approach frees the healthcare enterprise to make future changes to underlying infrastructure with minimal disruption.

“When we first began looking at a PACS replacement or upgrade a few years ago, we were very worried about change management. A change in system meant disruption for our physicians’ workflow and a support nightmare for our imaging and IT team,” says Rafael Gonzalez, executive director of imaging and information technologies at Aultman. “Then we discovered eUnity. More than any other product, it offered us a truly universal solution. It was vendor-neutral, browser-neutral and a completely agnostic solution that can work with anything. It supports all types of imaging and also offers incredibly fast querying of images from a variety of sources.”

“Aultman worked with the Client Outlook team to configure eUnity specific to the needs of its physicians, adding new hanging protocols to address how images first open, and image enabling their electronic medical records (EMR) system to allow users to open images in context with all of the other patient data,” says Brenda Rankin, Executive Vice President, Client Outlook. “Aultman and Client Outlook are working closely together to shape the future of enterprise image viewing, such as viewing EKGs — a current viewing challenge no other vendor can solve.”

“I keep saying the industry has it all backwards. What healthcare enterprises need is a universal viewer that can query anything and work with any underlying system. Then you are free to use any system you want,” says Gonzalez.

Availability

eUnity™ is available for iOS on the Apple App Store, for Android through Google Play. When used on mobile devices, eUnity™ is for reference and referral only.

About Client Outlook, Inc.

Client Outlook is an innovative healthcare technology company who design imaging solutions that ultimately save people’s lives. Driven by our own personal healthcare experiences, we challenge ourselves every day to develop and deliver the most practical, useful and secure diagnostic, clinical and mobility solution for physicians and frontline healthcare professionals — right where healthcare happens. For more information about our company and our eUnity™ product suite, visit us on the web at www.clientoutlook.com

Show
Hide